Skip to main content
. Author manuscript; available in PMC: 2011 Oct 15.
Published in final edited form as: Clin Cancer Res. 2010 Oct 13;16(20):5019–5027. doi: 10.1158/1078-0432.CCR-10-0755

Table 1.

Characteristics of Females and Matched Males with SCCHN.

Females (n = 286)
Males (n = 286)
Variable N (%) N (%) P Value
Age* category .788
 < 50 years 76 (26.6) 69 (24.1)
 50–69 years 172 (60.1) 179 (62.6)
 ≥ 70 years 38 (13.3) 38 (13.3)
Race/ethnicity* 1.0
 White, Anglo, Caucasian 264 (92.3) 264 (92.3)
 Spanish origin 10 (3.5) 10 (3.5)
 African American 12 (7.7) 12 (7.7)
Adult comorbidity classification .078
 None or mild 257 (89.9) 243 (85.0)
 Moderate or severe 29 (10.1) 43 (15.0)
Smoking status* .980
 Current smoker 140 (49.0) 142 (49.7)
 Former smoker 75 (26.2) 73 (25.5)
 Never smoker 71 (24.8) 71 (24.8)
Alcohol drinking status <.001
 Current drinker 110 (38.5) 162 (56.6)
 Former drinker 50 (17.5) 71 (24.8)
 Never drinker 126 (44.1) 53 (18.5)
Marital status .002
 Married 185 (66.6) 215 (77.9)
 Widowed, divorced, or separated 81 (29.1) 46 (16.7)
 Never married 12 (4.3) 15 (5.4)
Educational level attained .840
 < High school 37 (13.3) 34 (12.4)
 High School, technichal or vocational school, or assoceate degree or some college 161 (57.9) 166 (60.3)
 Bachelor's degree or advanced degree 80 (28.8) 75 (27.3)
Income level .281
 < $25,000 75 (27.8) 59 (22.0)
 $25,000–74,999 112 (41.5) 116 (43.3)
 ≥ $75,000 83 (30.7) 93 (34.7)
Tumor site* 1.0
 Oral cavity 132 (46.2) 132 (46.2)
  Oral tongue or floor of mouth 88 88
  Gingivobuccal^ 44 44
 Oropharynx 92 (32.2) 92 (32.2)
  Tonsil 48 43
  Other oropharynx 44 49
 Larynx 55 (19.2) 55 (19.2)
  Supraglottic 43 34
  Glottic 12 21
 Hypopharynx 7 (2.4) 7 (2.4)
Tumor classification* .992
 T1 77 (26.9) 74 (25.9)
 T2 104 (36.4) 107 (37.4)
 T3 55 (19.2) 55 (19.2)
 T4 50 (17.5) 50 (17.5)
Nodal classification* .247
 N0 140 (49.0) 140 (49.0)
 N1 49 (17.1) 34 (11.9)
 N2 89 (31.1) 105 (36.7)
 N3 8 (2.8) 7 (2.4)
Stage .621
 I 56 (19.6) 54 (18.9)
 II 54 (18.9) 56 (19.6)
 III 55 (19.2) 44 (15.4)
 IV 121 (42.3) 132 (46.2)
Grade# .995
 Well differentiated 34 (11.9) 34 (11.9)
 Moderately differentiated 140 (49.0) 141 (49.3)
 Poorly differentiated 76 (26.6) 75 (26.2)
Treatment* 1.0
 Surgery alone 85 (29.7) 85 (29.7)
 Surgery + radiotherapy 45 (15.7) 45 (15.7)
 Surgery + chemotherapy 1 (0.3) 1 (0.3)
 Surgery + chemoradiotherapy 21 (7.3) 21 (7.3)
 Radiotherapy alone 64 (22.4) 64 (22.4)
 Chemoradiotherapy 70 (24.5) 70 (24.5)
*

Matched variables (age, ± 10 years; race/ethnicity, smoking status, ever versus never; tumor site, oral cavity versus oropharynx versus larynx versus hypopharynx; tumor classification, T1–2 versus T3–4; nodal classification, N0 versus N1–3; and treatment).

Missing data: 8 women and 10 men for marital status; 8 women and 11 men for education level attained; 16 women and 18 men for income level.

#

Grade was not recorded in 36 females and 36 males.

^

One female and the corresponding matched male had a primary tumor of the mandibular gingiva and a simultaneous second primary tumor of the oropharynx.